Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

Tyrosine kinase inhibitors show promise in treating some skin diseases but their definitive role in dermatology is still unclear.

Tofacitinib may help regrow hair in severe alopecia areata, but results differ greatly between people.

The guideline provides recommendations for managing alopecia areata effectively.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

JAK inhibitors help treat alopecia areata but have high recurrence after stopping.

The FDA approved Litfulo® for treating severe alopecia areata in people aged 12 and older.

Certain drugs can change hair color, either lightening or darkening it.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

A Brazilian teenager with severe hair loss had total hair regrowth with no side effects after using tofacitinib.

New small molecule drugs show promise in treating complex skin diseases but need more safety research.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

A patient with complete hair loss regrew all her hair using tofacitinib.

Upadacitinib may effectively treat alopecia areata without side effects.

Some leukemia treatments can cause skin reactions similar to keratosis pilaris.

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

Gray hair can potentially be reversed, leading to new treatments.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

Alopecia areata is hard to treat, but new targeted therapies show promise.

Tyrosine kinases are important in skin autoimmune diseases and could be targets for new treatments.

Ritlecitinib is effective for long-term hair regrowth in alopecia areata, especially in females and early treatment.

Tofacitinib helped regrow hair in a patient with severe hair loss and improved their quality of life without side effects.

Tofacitinib can help hair grow back in alopecia patients but hair loss might return if the dose is lowered.

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

Baricitinib shows promise for treating alopecia areata with mild side effects.

Tofacitinib was found to be a safe and effective treatment for hair regrowth in patients with alopecia areata.

Oral and topical tofacitinib can help regrow hair in people with severe alopecia areata.

A combination of ixekizumab and tofacitinib successfully treated severe scalp cellulitis, leading to hair regrowth.